Beijing Leadman Biochemistry Co.,Ltd.

300289.SZ · Shenzhen Stock Exchange · CNY

6,01CNY

+0,05 (+0,84 %)Stand 10. Nov., 7:04

Vortag 5,96

Kennzahlen

Eröffnung
5,96
Vortag
5,96
Tagesspanne
5,96 – 6,07
52 Wochen
5,19 – 10,41
Volumen
6,45 Mio.
Ø Volumen
8,04 Mio.
Börsenwert
3,27 Mrd. CNY
KGV
–
Gewinn je Aktie (TTM)
–
Dividendenrendite
–
Beta
0,2
Nächste Zahlen
–

Finanzen

Gerade nicht verfügbar.

Bewertung

Gerade nicht verfügbar.

Analysten

Einstufungen

Gerade nicht verfügbar.

Kursziel

Gerade nicht verfügbar.

Quartalszahlen

Gerade nicht verfügbar.

Dividenden und Splits

Gerade nicht verfügbar.

Aktiensplits

Gerade nicht verfügbar.

Eigentümer

Institutionen

Gerade nicht verfügbar.

Insider-Geschäfte

Gerade nicht verfügbar.

Vergleichbare Unternehmen

Gerade nicht verfügbar.

Über das Unternehmen

Beijing Leadman Biochemistry Co.,Ltd. is a prominent entity within the People's Republic of China, specializing in the entire lifecycle – from research and development to manufacturing and distribution – of advanced in vitro diagnostic (IVD) solutions. Its product portfolio encompasses a comprehensive range of biochemical raw materials. This includes critical components like enzymes, coenzymes, antibodies, various buffers, enzyme substrates, culture media, staining reagents, and amino acids. These essential ingredients serve a diverse array of sectors, notably biotechnology, clinical diagnostics, pharmaceutical development, and chemical manufacturing. Beyond raw materials, Leadman also provides specialized biochemistry diagnostic and complementary reagents. Furthermore, the company supplies a sophisticated selection of medical instrumentation. This lineup features the EnigmaML, an automated molecular testing platform designed for both clinical laboratories and various point-of-care settings like clinics and pharmacies. Another key offering is the DiaSys InnovaStar, a compact automated POCT analyzer that delivers laboratory-grade diagnostic accuracy. Customers also benefit from the DiaSys Respons, a versatile random access benchtop analyzer; the CI1000 automatic chemiluminescence immunoassay analyzers; and the IDS-isys, an instrument engineered to boost operational performance and efficiency. Established in 1997, Beijing Leadman Biochemistry maintains its corporate headquarters in Beijing, China.

CEO
Ouyang Xu
Mitarbeitende
420
Hauptsitz
Beijing, BE, CN
Sektor
Healthcare
Branche
Medical - Devices
Börsengang
16. Feb. 2012

Nachrichten

Gerade nicht verfügbar.

Kurse mindestens 15 Minuten verzögert. Daten: Financial Modeling Prep. Keine Anlageberatung.